Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Selective antisense oligonucleotide inhibition of human IRF4 prevents malignant myeloma regeneration via cell cycle disruption

20 Jan 2021

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Multiple Myeloma Research and Treatments
Share to Protein Degradation and Inhibitors
Share to Ubiquitin and proteasome pathways

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 33476575
DOI: 10.1016/j.stem.2020.12.017

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Selective antisense oligonucleotide inhibition of human IRF4 prevents malignant myeloma regeneration via cell cycle disruptionPMID 33476575Read ↗

Antitumour actions of interferons: implications for cancer therapySemantic proximity Read ↗

Telomerase Inhibition Effectively Targets Mouse and Human AML Stem Cells and Delays Relapse following ChemotherapySemantic proximity Read ↗

Fibroblast growth factor receptor 3 inhibition by short hairpin RNAs leads to apoptosis in multiple myelomaSemantic proximity Read ↗

Reversing Radiation-Induced Immunosuppression Using a New Therapeutic ModalitySemantic proximity Read ↗

Disruption of immunoglobulin heavy and light chain assembly by antisense oligonucleotides impairs protein homeostasis and myeloma cell survivalSemantic proximity Read ↗

Splice switching oligonucleotide mediated gene knockdown in B cells and plasma cellsSemantic proximity Read ↗

The transcription factor IRF4 represses proapoptotic BMF and BIM to licence multiple myeloma survivalSemantic proximity Read ↗

Pharmacologic reversal of epigenetic silencing of the anticancer protein BRM: a novel targeted treatment strategySemantic proximity Read ↗

Epigenetic silencing of miR-137 induces drug resistance and chromosomal instability by targeting AURKA in multiple myelomaSemantic proximity Read ↗

<i>In vivo</i> inducible reverse genetics in patients’ tumors to identify individual therapeutic targetsSemantic proximity Read ↗

RNA interference-mediated silencing of iASPP induces cell proliferation inhibition and G0/G1 cell cycle arrest in U251 human glioblastoma cellsSemantic proximity Read ↗

Changes in gene expression induced by phosphorothioate oligodeoxynucleotides (including G3139) in PC3 prostate carcinoma cells are recapitulated at least in part by treatment with interferon-beta and -gamma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.